Transurethral needle ablation of the prostate: An alternative minimally invasive therapeutic concept in the treatment of benign prostate hyperplasia

Urologia Internationalis

Volumn 61, Issue 2, 1998, Pages 104-110

  Braun, M ^a,d   Zumbe J ^b   Korte, D ^a   Solleder, G ^c   Heidenreich, A ^a   Engelmann, U ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b St Marienhospital ^*  (Germany)

^c Urologische Abteilung   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Benign prostate hyperplasia; Clinical results; Radiofrequency; Thermoablation

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOMETRY; CYSTOSCOPY; HUMAN; MALE; MINIMALLY INVASIVE SURGERY; NEEDLE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RESIDUAL URINE; TRANSURETHRAL RESECTION; URINE FLOW RATE; URODYNAMICS;

AGED; CATHETER ABLATION; CYSTOSCOPY; ENDOSCOPES; ENDOSCOPY; FOLLOW-UP STUDIES; HUMANS; MALE; NEEDLES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; SAFETY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; URETHRA; URODYNAMICS;

EID: 0032414733     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030298     Document Type: Article

References (27)

1. Calkins H, Langberg J, Sousa J, El-Atassi R, Leon A, Kou W, Kalbfleisch S, Morady F: Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrom. Circulation 1992; 85:1337-1347.
2. Campo B, Muto G, Rigatti P, Bergmaschi F, Moroni A, Colombo R, Corrada P: TUNA™: Clinical reability of a new procedure of prostatic obstruction treatment. J Urol (abstract) 1995;153:533.
3. Dahlstrand C, Christensen G, Fall M, Pettersson S: Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: Preliminary results of a randomised study. Eur Urol 1993;23:292-298.
4. Dixon CM: Transurethral needle ablation for the treatment of benign prostatic hyperplasia. Urol Clin North Am 1995;22:441-444.
5. Drummond MF, McGuire AJ, Black NA, Petticrew M, McPherson CK: Economic burden of treated BPH in the United Kingdom. Br J Urol 1993;71:290-296.
6. Foster RS, Bihrle R, Saghvi TN, Donohue JP, Fey FJ: High intensity focused ultrasound treatment of human BPH. Progress in Clinical and Biological Research 1994;386:463-471.
7. Garraway WM, Collins N, Lee RJ: High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338:468-471.
8. Glynn RJ, Campion EW, Bouchard GR, Silbert JE: The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidermol 1985;121: 78-90.
9. Goldwasser B, Ramon J, Engelberg S, Ohad D, Sharkey H, Strul B, Rasor JS, Edwards SD: Transuretheral needle ablation (TUNA) of the prostate using low radiofrequency energy: An animal experimental study. Eur Urol 1993;24: 400-405.
10. Gormley G, Stoner JE: Clinical results with finasteride. Prog Clin Biol Res 1994;386:205-207.
11. Heaton JPW: Radiofrequency thermal ablation of the prostate: The TUNA™-technique. Tech in Urol 1995;1:3-10.
12. Issa M, Kabalin JN: Transurethral needle ablation of the prostate: Report of initial United States clinical trial. J Urol (abstract):195;153: 535.
13. Issa MM, Oesterling JE: Transurethral needle ablation (TUNA™). An overview of radiofrequency thermal therapy for the treatment of benign prostatic hyperplasia. Curr Opin Urol 1996;6:20-27.
14. Jardin A, Bensadoun H, Delauche-Cavallier MC, Attali P: BPH-ALF Group. Alfuzosin for treatment of benign prostatic hypertrophy. Lancet 1991;337:1457-1461.
15. Laduc R, Weil EHJ, Zerbib M, Perrin P, Denis L: Thermotherapy and Hyperthermia Workshop. Prog Clin Biol Res 1994;386:487-498.
16. Madersbacher S, Kratzik C, Susani M, Marberger M: Minimal invasive Therapie der benignen Prostatahyperplasie mit fokussiertem Ultraschall. Urologe [A] 1995;34:98-104.
17. Malenka DJ, Roos N, Fischer ES, McLerran D, Whaley FS, Barry MJ, Bruskewitz R, Wennberg JE: Further study of the increased mortality following transurethral prostatectomy: A chart-based analysis. J Urol 1990;144:224-228.
18. Muschter R, Hessel S, Hofstetter A, Keidisch E, Rothenberger KH, Scheede P, Frank F: Die interstitielle Laserkoagulation der benignen Prostatahyperplasie. Urologe A 1993;32:273-278.
19. Muschter R, Zellner M, Hessel S, Hofstetter A: Die interstitielle laserinduzierte Koagulation (ILK) zur Therapie der benignen Prostatahyperplasie (BPH). Urologe A 1995;34:90-97.
20. Organ LW: Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol 1976;39:69-76.
21. Perachino M, Bozzo W, Puppo P, Vitali A, Aroino S, Ferro MA: Does transurethral thermotherapy induce a long-term alpha blockade? An immunohistochemical study. Eur Urol 1993;23:299-301.
22. Rasor JS, Zlotta AR, Edwards SD, Schulman CC: Transurethral needle ablation (TUNA): Thermal gradient mapping and comparison of lesion size in a tissue model and in patients with benign prostatic hyperplasia. Eur Urol 1993:24:411-414.
23. Schulman CC, Zlotta AR: Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experience. Urol 1995;45:28-33.
24. Van Swol CFP, Verdaasdonk M, Mooibroek J, Boon TA: Optimization of laser prostatectomy. Progress in Clinical and Biological Research 1994;386:511-519.
25. Woo HH, Rosario DJ, Potts KL, Hastie KJ, Chapple CR: The treatment of objectively documented prostatic obstruction by transurethral needle ablation of the prostate. J Urol (abstract) 1995;153:534.
26. Zlotta AR, Schulman CC: Transurethral needle ablation of the prostate: A new treatment of benign prostatic hyperplasia using interstitial low level radiofrequency energy. Curr Opin Urol 1995;5:35-38.
27. Zlotta AR, Raviv G, Peny MO, Fourmarier M, Louis L, Haot J, Schulman CC: What are the possible mechanisms of action of transurethral needle ablation of the prostate (TUNA™) on BPH symptoms and where is the ideal location of lesions? Eur Urol Suppl 1996;30:608.